To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Daniel Isaac, MS, DO, completed his Bachelor’s of Science and Master’s of Science in mechanical engineering at Michigan State University. He then went on to attend the Edward Via College of Osteopathic Medicine at Virginia Tech in Blacksburg, VA. He has received numerous honors and awards, including the Medical Student of the Year Award at Edward Via Virginia College of Osteopathic Medicine in 2012 and National Medical Student Abstract Competition Winner from the American College of Physicians in 2013.
Dr. Isaac completed his residency training in internal medicine at William Beaumont Hospital in Royal Oak. After completion, he returned to East Lansing to join the Hematology/Oncology Fellowship Program at Michigan State University. He was the chief fellow at MSU and will complete his fellowship in 2019. Dr. Isaac joined the department in August 2019.
Isaac has completed research at Michigan State University on the translational effects of TCH-165 and derivatives on relapsed multiple myeloma as well as research on immune microenvironment modulation in prostate cancer. His clinical interests will focus on genitourinary cancers. He joined the Michigan Society of Hematology and Oncology (MSHO) Board as a second-year fellow member in 2018. He will serve on the board through September 2019.
WILX Daniel Isaac, D.O., MS , hematologist and medical oncologist, member of the Breast Cancer and Genitourinary Oncology Multidisciplinary Teams (MDT) at Karmanos, joined Studio 10. He explained the collaborative relationship physicians at Karmanos Cancer Institue at McLaren Greater Lansing have with their MDT members at the headquarters in Detroit, the significance of the partnership with MSU Health Care, and the specializations of each oncologist at the Lansing location. Watch the interview here .
Like many others, Jaimie Hutchison had put off her mammogram during the COVID-19 pandemic. Routine health screenings, including cancer screenings, saw a significant drop during this time due to stay-at-home orders and other disruptions caused by the pandemic, leaving a gap in early detection of cancer. “I had just been promoted at my job and had been feeling very tired, brushing it off as pandemic fatigue, but I knew I had to get back to scheduling and getting my health screenings that I was behind on,”...
The Barbara Ann Karmanos Cancer Institute ’s 11th Annual Pink Out the Park event with the Detroit Tigers and McLaren Health Care, the official health care system of the Tigers, was a home run in Motor City. As the Tigers battled against the Seattle Mariners on Friday, May 12, 2023, hundreds of breast cancer survivors and their loved ones filled the stands at Comerica Park, decorated in pink to promote breast cancer awareness and support. “It is gratifying to see so much support from the community of sur...